S'abonner

Enhanced case management can be delivered for patients with EVD in Africa: Experience from a UK military Ebola treatment centre in Sierra Leone - 05/04/18

Doi : 10.1016/j.jinf.2017.12.006 
S.J. Dickson a, K.A. Clay a, M. Adam a, C. Ardley a, M.S. Bailey a, D.S. Burns a, A.T. Cox a, D.G. Craig a, M. Espina b, I. Ewington a, G. Fitchett a, J. Grindrod a, D.E. Hinsley a, S. Horne a, E. Hutley a, A.M. Johnston a, R.L.C. Kao b, L.E. Lamb a, S. Lewis a, D. Marion b, A.J. Moore a, T.C. Nicholson-Roberts a, A. Phillips a, J. Praught b, P.S. Rees a, I. Schoonbaert b, T. Trinick a, D.R. Wilson a, A.J. Simpson c, D. Wang d, M.K. O'Shea a, T.E. Fletcher a, d, *
a U.K. Defence Medical Services EVD Group, Royal Centre for Defence Medicine, Birmingham, United Kingdom 
b Royal Canadian Medical Services, Ottawa, Canada 
c Rare and Imported Pathogens Laboratory, Public Health England, Porton, United Kingdom 
d Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, United Kingdom 

*Corresponding author. Dept of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, United Kingdom.Dept of Clinical SciencesLiverpool School of Tropical MedicineLiverpoolL3 5QAUnited Kingdom

Highlights

EVD is associated with life-threatening electrolyte imbalance and organ dysfunction.
Clinical staging/early warning scores can be useful EVD prognostic indicators.
Enhanced protocolized care is a blueprint for future treatment in low-resource settings.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

Limited data exist describing supportive care management, laboratory abnormalities and outcomes in patients with Ebola virus disease (EVD) in West Africa. We report data which constitute the first description of the provision of enhanced EVD case management protocols in a West African setting.

Methods

Demographic, clinical and laboratory data were collected by retrospective review of clinical and laboratory records of patients with confirmed EVD admitted between 5 November 2014 and 30 June 2015.

Results

A total of 44 EVD patients were admitted (median age 37 years (range 17–63), 32/44 healthcare workers), and excluding those evacuated, the case fatality rate was 49% (95% CI 33%–65%). No pregnant women were admitted. At admission 9/44 had stage 1 disease (fever and constitutional symptoms only), 12/44 had stage 2 disease (presence of diarrhoea and/or vomiting) and 23/44 had stage 3 disease (presence of diarrhoea and/or vomiting with organ failure), with case fatality rates of 11% (95% CI 1%–58%), 27% (95% CI 6%–61%), and 70% (95% CI 47%–87%) respectively (p = 0.009). Haemorrhage occurred in 17/41 (41%) patients. The majority (21/40) of patients had hypokalaemia with hyperkalaemia occurring in 12/40 patients. Acute kidney injury (AKI) occurred in 20/40 patients, with 14/20 (70%, 95% CI 46%–88%) dying, compared to 5/20 (25%, 95% CI 9%–49%) dying who did not have AKI (p = 0.01). Ebola virus (EBOV) PCR cycle threshold value at baseline was mean 20.3 (SD 4.3) in fatal cases and 24.8 (SD 5.5) in survivors (p = 0.007). Mean national early warning score (NEWS) at admission was 5.5 (SD 4.4) in fatal cases and 3.0 (SD 1.9) in survivors (p = 0.02). Central venous catheters were placed in 37/41 patients and intravenous fluid administered to 40/41 patients (median duration of 5 days). Faecal management systems were inserted in 21/41 patients, urinary catheters placed in 27/41 and blood component therapy administered to 20/41 patients.

Conclusions

EVD is commonly associated life-threatening electrolyte imbalance and organ dysfunction. We believe that the enhanced levels of protocolized care, scale and range of medical interventions we report, offer a blueprint for the future management of EVD in resource-limited settings.

Le texte complet de cet article est disponible en PDF.

Keywords : Ebola virus disease, Viral haemorrhagic fever, Critical care, Early warning score


Plan


© 2017  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 76 - N° 4

P. 383-392 - avril 2018 Retour au numéro
Article précédent Article précédent
  • IL-6 release of Rv0183 antigen-stimulated whole blood is a potential biomarker for active tuberculosis patients
  • Yongliang Liu, Xiaofei Li, Wei Liu, Yang Liu, Zhouyue Zhong, Lili Wang, ShengXiang Ge, Jun Zhang, Ningshao Xia
| Article suivant Article suivant
  • Vaginal and anal human papillomavirus infection and seropositivity among female sex workers in Amsterdam, the Netherlands: Prevalence, concordance and risk factors
  • E. Marra, N. Kroone, E. Freriks, C.L. van Dam, C.J. Alberts, A.A. Hogewoning, S. Bruisten, A. van Dijk, M.M. Kroone, T. Waterboer, M.F. Schim van der Loeff

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.